Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

1DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 3,4,3-li(1,2-hopo), Unii-r6sml525fn, 110874-36-7, R6sml525fn, Kun74367, 2-pyridinecarboxamide, n,n'-1,4-butanediylbis(n-(3-(((1,6-dihydro-1-hydroxy-6-oxo-2-pyridinyl)carbonyl)amino)propyl)-1,6-dihydro-1-hydroxy-6-oxo-

Molecular Formula

C₃₄H₃₈N₈O₁₂

Molecular Weight

750.7 g/mol

InChI Key

KUWKQASGHNTJAT-UHFFFAOYSA-N

FDA UNII

R6SML525FN

1 2D Structure

3,4,3-Li(1,2-hopo)

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

1-hydroxy-N-[3-[(1-hydroxy-6-oxopyridine-2-carbonyl)-[4-[(1-hydroxy-6-oxopyridine-2-carbonyl)-[3-[(1-hydroxy-6-oxopyridine-2-carbonyl)amino]propyl]amino]butyl]amino]propyl]-6-oxopyridine-2-carboxamide

2.1.2 InChI

InChI=1S/C34H38N8O12/c43-27-13-3-9-23(39(27)51)31(47)35-17-7-21-37(33(49)25-11-5-15-29(45)41(25)53)19-1-2-20-38(34(50)26-12-6-16-30(46)42(26)54)22-8-18-36-32(48)24-10-4-14-28(44)40(24)52/h3-6,9-16,51-54H,1-2,7-8,17-22H2,(H,35,47)(H,36,48)

2.1.3 InChI Key

KUWKQASGHNTJAT-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=CC(=O)N(C(=C1)C(=O)NCCCN(CCCCN(CCCNC(=O)C2=CC=CC(=O)N2O)C(=O)C3=CC=CC(=O)N3O)C(=O)C4=CC=CC(=O)N4O)O

2.2 Other Identifiers

2.2.1 UNII

R6SML525FN

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 1,5,10,14-tetra(1-hydroxy-2-pyridon-6-oyl)-1,5,10,14-tetraazatetradecane

2. 3,4,3-li(1,2-hopo)

3. 3,4,3li(1,2-hopo)

2.3.2 Depositor-Supplied Synonyms

1. 3,4,3-li(1,2-hopo)

2. Unii-r6sml525fn

3. 110874-36-7

4. R6sml525fn

5. Kun74367

6. 2-pyridinecarboxamide, N,n'-1,4-butanediylbis(n-(3-(((1,6-dihydro-1-hydroxy-6-oxo-2-pyridinyl)carbonyl)amino)propyl)-1,6-dihydro-1-hydroxy-6-oxo-

7. N,n'-(butane-1,4-diyl)bis(1-hydroxy-n-(3-(1-hydroxy-6-oxo-1,6-dihydropyridine-2-carboxamido)propyl)-6-oxo-1,6-dihydropyridine-2-carboxamide)

8. N,n'-butane-1,4-diylbis[1-hydroxy-n-(3-{[(1-hydroxy-6-oxo-1,6-dihydropyridin-2-yl)carbonyl]amino}propyl)-6-oxo-1,6-dihydropyridine-2-carboxamide]

9. Chembl264485

10. Schembl13531452

11. Ex-a6322

12. 1-hydroxy-n-[3-[(1-hydroxy-6-oxopyridine-2-carbonyl)-[4-[(1-hydroxy-6-oxopyridine-2-carbonyl)-[3-[(1-hydroxy-6-oxopyridine-2-carbonyl)amino]propyl]amino]butyl]amino]propyl]-6-oxopyridine-2-carboxamide

13. Q27287867

14. 2,2',2'',2'''-(1,5,10,14-tetraazatetradecane-1,5,10,14-tetryltetrakiscarbonyl)tetrakis(6-hydroxypyridine 1-oxide)

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₃₄H₃₈N₈O₁₂
Molecular Weight	750.7 g/mol
XLogP3	0.9
Hydrogen Bond Donor Count	6
Hydrogen Bond Acceptor Count	12
Rotatable Bond Count	17
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	261
Heavy Atom Count	54
Formal Charge	0
Complexity	1690
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1